Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Marie Sebert, Lucie Freiman,Cendrine Chaffaut, Agnes Guerci,Pierre Peterlin,Sylvain Thepot, Odile Beyne-Rauzy,Sophie Park, Thomas Cluzeau,Fatiha Chermat, Pierre Fenaux,Claude Preudhomme,Emmanuelle Clappier, Sylvie Chevret,Lionel Ades, Nicolas Duployez,Matthieu Duchmann LEUKEMIA（2024）
AI 理解论文
溯源树
样例
